The impairment of midbrain nigrostriatal dopaminergic innervation at the striatum and the resulting imbalance of striatal output via the direct and indirect pathways underlie the neurological basis of Parkinson's disease-related movement disorders 1 . Parkinson's disease also causes substantial alterations in dendritic spine morphology and function of SPNs 2,3 . The striatum consists of more than 90% of SPNs and they are located in two complementary compartments named striosomes and matrix 4 . Notably, LRRK2, one of the most common genetic factors associated with both familial and sporadic Parkinson's disease 5 , is particularly enriched in the striosomal SPNs as compared with low expression in the nigrostratal dopaminergic neurons 6 . This distinct expression pattern suggests that LRRK2 may be important in the SPNs in response to dopamine stimulation. However, little is known about the pathophysiological functions of LRRK2 in the SPNs under either normal physiological or disease conditions.
a r t I C l e S
The impairment of midbrain nigrostriatal dopaminergic innervation at the striatum and the resulting imbalance of striatal output via the direct and indirect pathways underlie the neurological basis of Parkinson's disease-related movement disorders 1 . Parkinson's disease also causes substantial alterations in dendritic spine morphology and function of SPNs 2,3 . The striatum consists of more than 90% of SPNs and they are located in two complementary compartments named striosomes and matrix 4 . Notably, LRRK2, one of the most common genetic factors associated with both familial and sporadic Parkinson's disease 5 , is particularly enriched in the striosomal SPNs as compared with low expression in the nigrostratal dopaminergic neurons 6 . This distinct expression pattern suggests that LRRK2 may be important in the SPNs in response to dopamine stimulation. However, little is known about the pathophysiological functions of LRRK2 in the SPNs under either normal physiological or disease conditions.
The onset of LRRK2 expression also coincides with the formation of dendritic spines during neuron development 7 . LRRK2 is involved in actin dynamics that regulate the extension of dendrites and axons in neuron morphogenesis 8 . Dendritic spine formation that is critical for the connectivity and plasticity in the brain is also determined by the actin cytoskeleton 9 . Spine morphogenesis involves the transition from the initial long, thin and highly flexible filopodia to the more stable spines that are considered to be mature when showing characteristic bulbous enlargements (spine head) and a distinct neck 10 . Cofilin, a modulator of actin filament turnover, critically regulates the dynamics of spine formation 11 . Cofilin activity is inhibited by LIM kinase-mediated phosphorylation and stimulated by Slingshotinduced de-phosphorylation on a highly conserved serine at residue three (S3) 12 . However, alternative regulatory mechanisms have been described, including a PKA-dependent pathway 13 .
PKA-mediated signaling pathways are critical for neuron development and function 14 . PKA holoenzyme contains two catalytic subunits and two regulatory subunits. Cyclic AMP (cAMP) activates the kinase activity of PKA by disrupting the association between the catalytic and regulatory subunits 15 . The mammalian PKA family can be subdivided into types I and II on the basis of their regulatory subunits 16 . The PKARIIβ regulatory subunit is particularly abundant in the SPNs 17, 18 . Dopamine can activate PKA signaling in the SPNs via binding with Drd1-like dopamine receptors 19 . The specificity and efficacy of PKA signaling in neurons can also be regulated by A kinase anchoring proteins (AKAPs), which determines the subcellular distribution of PKA holoenzyme by interacting with the regulatory subunits 20 .
We found that LRRK2 is an AKAP-like regulator of the subcellular distribution of PKARIIβ in neurons and observed a previously unknown physiological role for LRRK2 as a negative modulator of PKA activity in the SPNs during synaptogenesis and in response to dopamine receptor activation. We further investigated the effect of Parkinson's disease-related Lrrk2 missense mutations on the PKA activity and found a pathogenic mechanism of LRRK2 that alters the response of SPNs to dopamine stimulation in Parkinson's diseaserelated LRRK2 R1441C knock-in mice.
RESULTS

LRRK2 regulates the SPN synaptogenesis and transmission
To extend our previous study on the role of LRRK2 in neuron development 8 , we investigated whether LRRK2 affects dendritic spine a r t I C l e S formation in SPNs. Notably, Golgi-Cox staining revealed a substantial decrease of dendritic spines and increase of dendritic filopodia in the dorsal SPNs of postnatal day 15 (P15) Lrrk2 knockout (Lrrk2 −/− ) pups compared with age-matched wild-type (Lrrk2 +/+ ) littermate controls (Fig. 1a,b) . When the dendritic spines were further categorized as thin mushroom or stubby on the basis of their maturation stages, a higher proportion of thin and less mushroom spines were found in the LRKK2 −/− neurons (Fig. 1c) . The cumulative frequency distribution analysis revealed that Lrrk2 −/− SPNs had substantially longer dendritic spines, whereas the spine heads were smaller (Fig. 1d,e) . The critical involvement of Lrrk2 in the maturation of dendritic spines was also supported biochemically by the reduction of postsynaptic density (PSD) protein PSD95 expression in striatal extracts of P15 and P21 Lrrk2 −/− mice ( Supplementary Fig. 1a,b) . We also measured the morphological changes of SPN dendritic spines in 1-month-old Lrrk2 −/− mice. The density and length of the dendritic spines were comparable between Lrrk2 +/+ and Lrrk2 −/− neurons, but the diameter of spine heads remains substantially smaller in the Lrrk2 −/− neurons ( Supplementary Fig. 1c-e) . Overall, the loss of Lrrk2 substantially alters the dendritic spine morphology in the SPNs, especially during the developmental stages.
To further examine whether the alteration of spine number and morphology in the Lrrk2 −/− SPNs affects synaptic transmission, we measured glutamatergic miniature excitatory postsynaptic currents (mEPSCs) in striatal slices from P15 Lrrk2 −/− and littermate control Lrrk2 +/+ mice by whole-cell voltage-clamp recordings (Fig.  1f) . Although the amplitude of mEPSCs was moderately increased in Lrrk2 −/− neurons (Fig. 1g) , the frequency of mEPSCs was substantially reduced (Fig. 1h) . To probe the pre-versus postsynaptic nature of these changes, we recorded the responses of SPNs to paired (b) The density of dendritic spines and filopodia (n = 3 pups per genotype). Data represent mean ± s.e.m., Mann-Whitney test (spine, z = 1.964; filopodia, z = −1.964). The inset shows a schematic representation of filopodium and different types of dendritic spines. (c) The distribution of different types of dendritic spines in Lrrk2 +/+ and Lrrk2 −/− SPNs (n Lrrk2 +/+ = 839 spines, n Lrrk2 −/− = 835 spines from six neurons of three pups per genotype, χ 2 (2) = 50.13, P < 0.0001). (d,e) Cumulative frequencies of spine head diameter (d, Kolmogorov-Smirnov test, P < 0.001) and spine length (e, Kolmogorov-Smirnov test, P < 0.001) in the spines of the SPNs described above. Scatter blots show average head diameter and length. Data represent mean ± s.e.m. (unpaired t test, t 4 = 1.839 and 3.853, respectively). (f) Traces of mEPSCs recorded from P15 Lrrk2 +/+ and Lrrk2 −/− SPNs. (g,h) Mean values and cumulative distribution for amplitude (g, unpaired t test, t 8 = 2.446; Kolmogorov-Smirnov test, P < 0.001) and frequency (h, unpaired t test, t 8 = 2.667; Kolmogorov-Smirnov test, P < 0.001) of mEPSCs from P15 pups (n Lrrk2 +/+ = 11 neurons, n Lrrk2 −/− = 13 neurons of five pups per genotype). Data represent mean ± s.e.m. (i) Paired-pulse facilitation (PPF) measured at a 50-ms inter-pulse interval and summary data for n Lrrk2 +/+ = 7 neurons, n Lrrk2 −/− = 7 neurons (t 12 = 0.6323).
npg a r t I C l e S stimuli and found that the paired-pulse facilitation showed no difference between the genotypes (Fig. 1i) . These findings suggest that LRRK2 primarily regulates the postsynaptic response of SPNs.
Lrrk2 −/− neurons show aberrant phosphorylation of cofilin We examined the expression level and activity of actin binding proteins in the striatal homogenate of Lrrk2 −/− and age-matched littermate control mice ( Supplementary Figs. 2a and 3a) . We found that, although the expression level of total cofilin was comparable, the phosphorylation of cofilin at the conserved residue S3 was substantially increased in P5-21 Lrrk2 −/− mouse brains compared with controls ( Fig. 2a,b and Supplementary Figs. 2a and 3a) . We observed increased phosphorylation of S3 (pS3) cofilin staining in neurons from Lrrk2 −/− hippocampal sections and in the dendritic spine of cultured Lrrk2 −/− hippocampal neurons ( Fig. 2c and  Supplementary Fig. 2b) . Notably, the reduction of pS3 cofilin in the Lrrk2 +/+ mice brain coincided with the increase of LRRK2 expression during the postnatal development (Fig. 2a) , suggesting that LRRK2 may . Data represent mean ± s.e.m. (unpaired t test, t = 2.510, 1.124, 2.275 and 2.270, respectively). Whiskers plots show the distribution of head spine diameter and dendritic spine length of transfected Lrrk2 −/− (h,i) and Lrrk2 +/+ neurons (l,m) (Lrrk2 −/− , n GFP = 73 spines from four neurons, n S3A-GFP = 80 spines from four neurons; Lrrk2 +/+ , n GFP = 101 spines from seven neurons, n S3D-GFP = 79 spines from four neurons). Data represent min to max (unpaired t test, t = 2.263, 1.932, 3.473 and 3.271, respectively). For the box and whisker plots, the bottom and top of the box are always the first and third quartiles, and the band inside the box is always the second quartile (the median). npg a r t I C l e S suppress the phosphorylation of cofilin. Consistent with this idea, the levels of pS3 cofilin were reduced in the brain of P2-15 LRRK2 transgenic mice ( Supplementary Figs. 2c and 3b) , which overexpress human wildtype LRRK2 (ref. 21) . Considering the lack of apparent physical interaction between cofilin and LRRK2 ( Supplementary Figs. 2d and 3c) , LRRK2 may regulate cofilin phosphorylation indirectly through modulating the activity of other protein kinases or phosphatases.
An elevation of pS3 cofilin affects spine formation The abnormal increase of pS3 cofilin may impair actin dynamics and spine formation in Lrrk2 −/− neurons. In support of this notion, we observed a substantial decrease of filamentous actin (F-actin) content in the dendritic spines of cultured Lrrk2 −/− neurons after 15 d in vitro (DIV; Fig. 2d,e) . The actin cytoskeleton protruding from the dendritic shaft of Lrrk2 −/− neurons appeared thin and elongated (Fig. 2d) , which is consistent with a higher incidence of thin filopodia like protrusions found in the P15 Lrrk2 −/− SPNs (Fig. 1a-c) .
To establish a direct connection between cofilin phosphorylation and spine morphology, we introduced either GFP-tagged active or inactive forms of cofilin into cultured Lrrk2 −/− or Lrrk2 +/+ hippocampal neurons and looked for alterations in dendritic spine morphology. We found that Lrrk2 −/− neurons transfected with the constitutively active cofilin S3A mutation 22 developed more and larger spines, and the transfection rescued the spine morphology defects in Lrrk2 −/− neurons ( Fig. 2f-i) . On the contrary, Lrrk2 +/+ neurons transfected with the inactive cofilin S3D mutation 22 displayed longer and smaller spines with a concomitant increase of filopodia as well as spines with abnormal long protrusions, similar to the alterations observed in Lrrk2 −/− neurons ( Fig. 2j-m) . These data suggest that the persistent phosphorylation of cofilin in the SPNs of P15 Lrrk2 −/− mice may alter the actin dynamics, resulting in abnormal dendritic spine morphology.
LRRK2 regulates pS3 cofilin via a PKA-dependent pathway
We next examined the signaling pathways by which LRRK2 regulates cofilin phosphorylation. LIM kinase and Slingshot are typically involved in the phosphorylation and de-phosphorylation of cofilin 12 . However, in P15 Lrrk2 −/− pups, no obvious alteration of LIMK1 phosphorylation, an indicator of LIMK1 kinase activity, was found between P15 Lrrk2 +/+ and Lrrk2 −/− brain extracts ( Supplementary Figs. 4a,b and 5a ). In addition, the phosphorylated and total levels of Slingshot-1 L (SSH1L), a member of the Slingshot family that dephosphorylates cofilin 23 , were also comparable between genotypes (Supplementary Figs. 4a,c and 5a). To identify alternative mechanisms of cofilin activity regulation by LRRK2, we compared the levels of pS3 cofilin by western blot analysis of cultured Lrrk2 +/+ and Lrrk2 −/− cortical neurons treated with the activators and inhibitors of various intracellular signaling pathways directly or indirectly related with the regulation of cofilin phosphorylation 24 . Lrrk2 +/+ and Lrrk2 −/− neurons displayed similar changes of cofilin phosphorylation levels in response to modulators of AKT/protein kinase B, phosphoinositide 3-kinase (PI3K), protein kinase C (PKC), mammalian target of rapamycin (mTOR), pyruvate dehydrogenase kinase (PDK1) and MAPK/ERK kinase (MEK) pathways ( Supplementary Figs. 4d-g and 5b,c) . In contrast, application of forskolin (FSK), which promotes the production of cAMP and activation of PKA pathway, caused a substantial increase in cofilin phosphorylation in Lrrk2 +/+ neurons, but not in Lrrk2 −/− neurons (Fig. 3a,b) . In addition, treatment with the PKA inhibitor PKI resulted in comparable levels of phosphorylated cofilin in Lrrk2 +/+ and Lrrk2 −/− neurons ( Fig. 3c,d ). These data suggest an impairment of PKA signaling regulation in Lrrk2 −/− neurons.
To further confirm these findings, we tested the effect of FSK application on the canonical PKA substrate cAMP response elementbinding protein (CREB) in Lrrk2 +/+ and Lrrk2 −/− neurons. FSK treatment induced a two fold increase of phosphorylated CREB (pCREB) in Lrrk2 +/+ neurons, but failed to increase the ratio of pCREB in Lrrk2 −/− neurons ( Supplementary Figs. 4h-j and 5d ). In addition, we found a substantial increase of pCREB in the nuclear extract of P15 Lrrk2 −/− striatal tissues (Supplementary Figs. 4k,l and 5e). These results suggest an aberrant upregulation of basal PKA activity in the developing Lrrk2 −/− neurons.
LRRK2 selectively interacts with PKARIIb
To determine at which level LRRK2 exerts its effect on PKA activation, we first examined the production of cAMP in cultured Lrrk2 +/+ and Lrrk2 −/− neurons treated with vehicle or FSK. In both conditions, no substantial difference in cAMP production was observed ( Supplementary Fig. 6a,b) . We next investigated whether LRRK2 directly interacts with PKA. Co-immunoprecipitation (co-IP) of LRRK2 with PKA subunits from the striatal extract of human LRRK2 transgenic mice 25 revealed a selective interaction between LRRK2 and the PKARIIβ subunit, but not with the catalytic subunit (PKACα) or other regulatory subunits (Fig. 4a) . The direct interaction of LRRK2 and PKARIIβ was further confirmed by an in vitro binding assay using recombinant LRRK2 and PKARIIβ proteins (Fig. 4b) . Although PKA can phosphorylate LRRK2 (ref. 26) , no stable direct interaction between LRRK2 and PKACα recombinant proteins was observed (Fig. 4c) . Moreover, endogenous LRRK2 and PKARIIβ proteins were co-IPed by an LRRK2-specific antibody from the light membrane fraction of Lrrk2 +/+ brain homogenates (Fig. 4d) , of which both LRRK2 and PKARIIβ were highly enriched ( Supplementary Figs. 6c and 7a) . In addition, endogenous PKARIIβ and PKACα proteins were also co-IPed with LRRK2 by a PKARIIβ-specific antibody (Fig. 4e) , suggesting that LRRK2 coexists with PKARIIβ and PKACα in the same protein complex via direct interaction with PKARIIβ.
Immunostaining revealed colocalization of endogenous LRRK2 and PKARIIβ signals in the dendrites of Lrrk2 +/+ hippocampal pyramidal neurons (Fig. 4f) . Although PKARIIβ staining was mainly distributed along the dendritic shaft and at the base of dendritic spines in Lrrk2 +/+ neurons ( Fig. 4g) , PKARIIβ signal was evenly distributed in the dendritic shaft and spines of Lrrk2 −/− neurons (Fig. 4f) . Figs. 6d-f and 7b,c) . Together, these observations suggest that LRRK2 may regulate PKA activity by controlling the subcellular localization of PKARIIβ along the dendritic shaft. Further co-IP experiments revealed that PKARIIβ selectively interacted with the Ras of complex proteins (ROC) domain of LRRK2, whereas deletion of the N-terminal 2-5 residues of PKARIIβ (PKARIIβ∆2-5) prevented the interaction of PKARIIβ with LRRK2 (Fig. 4h,i) .
LRRK2 confines PKARIIb to the dendritic shafts
To further investigate the alteration of PKARIIβ subcellular localization in Lrrk2 −/− neurons (Fig. 4f) , we transfected cultured Lrrk2 +/+ and Lrrk2 −/− hippocampal neurons with GFP-tagged PKARIIβ and the cell volume marker mCherry. Confocal imaging revealed a predominant presence of PKARIIβ in the dendritic shafts of Lrrk2 +/+ neurons (Fig. 5a) . In contrast, we observed a substantial increase of dendritic spine PKARIIβ signal in Lrrk2 −/− neurons (Fig. 5a,b) . A similar increase of GFP-tagged PKACα in the dendritic spines was also observed in Lrrk2 −/− neurons ( Fig. 5c and Supplementary  Fig. 7d) . Furthermore, subcellular fractionation of P15 mouse forebrain tissues revealed a substantial increase of PKARIIβ and PKACα levels in the postsynaptic density (PSD) fraction of Lrrk2 −/− samples compared with the age-matched Lrrk2 +/+ controls ( Fig. 5d-f) . These findings indicate that LRRK2 is involved in controlling the accessibility of PKARIIβ and PKA holoenzyme into the dendritic spines.
Reintroduction of myc-tagged WT Lrrk2 into Lrrk2 −/− neurons prevented the dendritic spine translocation of PKARIIβ, confirming that LRRK2 has a direct effect on the subcellular localization of PKARIIβ (Supplementary Fig. 7e) . Moreover, transfection of PKARIIβ∆2-5, which disrupted the interaction of PKARIIβ with (Supplementary Fig. 7f ). In contrast, linking the MAP2 microtubule-binding domain (MTDB) with PKARIIβ∆2-5, which allows for a direct association of PKARIIβ∆2-5 with the microtubules 27 , prevented the localization of PKARIIβ∆2-5 into the dendritic spine of Lrrk2 +/+ neurons (Supplementary Fig. 7f) . Notably, PKARIIβ-∆2-5-MTBD was also excluded from the spines of Lrrk2 −/− neurons (Supplementary Fig. 7g ), emphasizing the importance of microtubule association in anchoring PKARIIβ in the dendritic shaft. Considering the fact that LRRK2 binds to microtubules and regulates the dynamic assembly of microtubule network 25, 28 , our data further support the importance of the LRRK2 microtubule binding property in providing the structural framework for retaining PKARIIβ in the dendritic shaft.
Alteration of GluR1 phosphorylation in Lrrk2 −/− neurons To examine the potential effect of aberrant PKA signaling on the postsynaptic targeting of AMPA-type glutamate receptors, we examined the PKA-dependent phosphorylation of GluR1 at residue serine 845 (pS845) 29 . The level of pS845GluR1 was substantially increased in the forebrain homogenate of P5 and P15 Lrrk2 −/− pups compared with age-matched littermate controls (Fig. 6a,b) . The difference in GluR1 phosphorylation disappeared in P30 Lrrk2 +/+ and Lrrk2 −/− mice (Fig. 6a,b) . FSK treatment did not further increase the level of pS845 GluR1 present in cultured Lrrk2 −/− neurons ( Supplementary  Figs. 8a,b and 9a,b) . The LRRK2 kinase inhibitor LRRK2-IN-1 (ref. 30 ) had no effect on FSK-induced phosphorylation of GluR1 and cofilin in cultured Lrrk2 +/+ neurons (Supplementary Figs. 8c-e and 9c) , suggesting npg a r t I C l e S that LRRK2 kinase activity is not involved in regulating PKA activity in neurons. The phosphorylation of GluR1 by PKA promotes the trafficking of GluR1 to synapses 31 . Although the overall level of GluR1 in the PSD fraction was substantially decreased in the brain homogenate of P15 Lrrk2 −/−−/− pups compared with littermate controls (Fig. 6c,d) , the level of GluR1 was actually higher in Lrrk2 −/− neurons when normalized against PSD95 protein (Fig. 6e) . These observations suggest that Lrrk2 −/− neurons may have less mature dendritic spines, but these mature spines may contain more GluR1 for synaptic transmission.
Dopamine activates the PKA signaling via Drd1 family dopamine receptors 19 . Intraperitoneal injection of a selective Drd1 agonist SKF81297 (ref. 32 ) resulted in a substantial increase of pS845 GluR1 in the striatal tissues of P21 Lrrk2 +/+ and Lrrk2 −/− mice, whereas substantially more pS845 GluR1 was detected in the Lrrk2 −/− samples (Fig. 6f,g ). Furthermore, SKF81297 stimulation also induced more pS845 GluR1 in the striatum of 18-month-old Lrrk2 −/− mice compared with age-matched controls (Fig. 6h) . In contrast, SKF81297 did not affect protein kinase C-mediated phosphorylation of GluR1 at S831 (ref. 33) in the striatum of P21 Lrrk2 +/+ and Lrrk2 −/− mice (Supplementary Figs.  8f,g and 9d) . Taken together, these data suggest an aberrant elevation of PKA activity induced by Drd1 activation in both young and aged Lrrk2 −/− mice, indicating that LRRK2 continues to function as a negative regulator of PKA after the postnatal developmental period. LRRK2 R1441C mutation impairs its regulatory role on PKA To examine the effect of Parkinson's disease-related LRRK2 missense mutations on the interaction with PKARIIβ, we found that the R1441C mutation at the ROC domain of LRRK2 substantially compromised the interaction between LRRK2 and PKARIIβ (Fig. 7a,b) . In vitro recombinant protein binding assays further confirmed the reduced interaction (43.33 ± 7.53%, unpaired t test, t 4 = 7.52, P = 0.0017) between R1441C LRRK2 and PKARIIβ (Fig. 7c) . We next examined the effect of R1441C LRRK2 on the subcellular localization of PKARIIβ in hippocampal neurons cultured from homozygous Lrrk2 R1441C knock-in (Lrrk2 R1441C/R1441C ) mice 34 The ambulatory (n), fine (o) and rearing movement (p) of P21 Lrrk2 +/+ , Lrrk2 −/− and Lrrk2 +/R1441C mice after treated with saline (n = 16, 37 and 10) or SKF81297 at 2 (n = 21, 28 and 11) and 10 mg per kg bodyweight (n = 27, 28 and 10). *P < 0.05, **P < 0.01, ***P < 0.001. Data represent mean ± s.e.m. (b,h,j,l-p). Unpaired t test (b,e,f,h,j,l,m) and two-way ANOVA (n-p) were used. The full-length blotas are shown in Supplementary Figure 10 . For the box and whisker plots, the bottom and top of the box are the first and third quartiles, the line inside the box is the median and the whiskers are the minima and maxima. npg a r t I C l e S PKARIIβ signal was found in the dendritic spine of Lrrk2 R1441C/ R1441C neurons compared with littermate control Lrrk2 +/+ neurons (Fig. 7d,e) . In addition, Lrrk2 R1441C/R1441C neurons displayed decreased spine area compared with controls (Fig. 7f) . In addition, we also observed a dose-dependent increase of pS3 cofilin and pS845 GluR1 in the brains of P15 Lrrk2 +/R1441C and Lrrk2 R1441C/R1441C mice (Fig. 7g-j) . Together, these data suggest that the R1441C mutation may compromise the regulatory function of LRRK2 on PKA during synaptogenesis.
To test the response of Lrrk2 +/R1441C and Lrrk2 R1441C/R1441C mice to dopamine stimulation, we found that SKF81297 treatment also induced an abnormal increase of pS845 GluR1 in the striatum of P21 and 18-month-old knock-in mice compared with age-matched control mice (Fig. 7k-m) . Notably, both Lrrk2 +/R1441C and Lrrk2 R1441C/R1441C mice showed similar alterations of GluR1 phosphorylation after treated with SKF81297 (Fig. 7l,m) .
To examine the functional consequence of Drd1 activation, we monitored the movement of saline-or SKF81297-treated P21 Lrrk2 +/+ , Lrrk2 −/− and Lrrk2 +/R1441C mice in the open-field test. Under saline treatment, Lrrk2 −/− mice showed substantially increased ambulatory, fine (for example, grooming) and rearing movements compared with Lrrk2 +/+ mice (Fig. 7n-p) . Although Lrrk2 +/R1441C mice displayed a similar increase of motor activity in the saline-treated condition, the difference was not substantial (Fig. 7n-p) . The administration of SKF81297 generally promoted the ambulatory and fine movements, but suppressed the rearing of control Lrrk2 +/+ mice (Fig. 7n-p) . Notably, both Lrrk2 −/− and Lrrk2 +/R1441C mice were substantially less responsive to higher dosage of SKF81297 stimulation compared with control mice (Fig. 7n-p) . These behavioral data suggest that the Lrrk2 R1441C missense mutation may compromise the normal function of LRRK2 in the SPNs in response to dopamine stimulation.
DISCUSSION
Our results provide substantial evidence that LRRK2 regulates synaptogenesis and dopamine receptor activation in the SPNs through modulation of PKA activity. We observed abnormal dendritic spine morphology and synaptic transmission in the SPNs of P15 Lrrk2 −/− pups, which may be attributable to the aberrant increase of PKA-mediated phosphorylation of S3 cofilin, S845 GluR1 and other substrates in the Lrrk2-deficient neurons. LRRK2 continued to regulate PKA activity in the SPNs of young and aged mice, as indicated by the abnormal phosphorylation of S845 GluR1 in response to dopamine receptor Drd1 activation, which may contribute to the reduced responsiveness of Lrrk2 −/− mice to the Drd1 agonist-induced motor activity. LRRK2 may regulate the specificity and efficacy of PKA signaling in the SPNs by selectively interacting with PKARIIβ subunits and controlling the predominantly dendritic shaft localization of PKA holoenzyme. Thus, a loss of LRRK2 allows more translocation of PKA holoenzyme into the dendritic spines, where PKA is in closer proximity to the source of cAMP production and the synaptic substrates 35 , resulting in excessive phosphorylation of key synaptic proteins involved in synaptic formation and transmission. Perhaps more notably, the Parkinson's diseaserelated Lrrk2 R1441C mutation substantially impaired the interaction between LRRK2 and PKARIIβ and resulted in similar alterations of PKA signaling as those seen in the Lrrk2 −/− counterparts. Thus, our findings provide new molecular insights into the pathophysiological mechanism of LRRK2 in Parkinson's disease.
In an attempt to identify the molecular components and signaling pathways underlying the dendritic spine morphological changes in Lrrk2 −/− neurons, we observed a substantial increase of cofilin phosphorylation in these neurons. The phosphorylation of cofilin is generally accepted to decrease its binding with F-actin and prevent its disassembly of F-actin 36 . Consistent with an earlier study 37 , the decrease of cofilin activity in Lrrk2 −/− neurons impaired the dynamic assembly of F-actin, as indicated by the decrease of F-actin content in the dendritic spines. Accordingly, the introduction of constitutively active S3A-cofilin in Lrrk2 −/− neurons increased F-actin content in the spines. The inhibition of cofilin activity by siRNA knockdown has also been shown to cause longer, thinner and more complex dendritic protrusions in cultured neurons 38 , as we observed in the Lrrk2 −/− neurons. Collaboratively, the introduction of S3A-cofilin rescued the dendritic spine abnormalities in the Lrrk2 −/− neurons. Notably, cofilin not only depolymerizes or severs F-actin according to the classical model, it also promotes the net assembly and polymerization of the newly generated barbed ends under specific conditions 39 , which may explain how the inactivation of cofilin reduced the F-actin content in the dendritic spine of Lrrk2 −/− neurons. Together, our observations reveal an active involvement of LRRK2 in the formation of dendritic spines via modulation of cofilin-mediated actin dynamics.
LRRK2 modulates the activity of PKACα by anchoring both PKACα and PKARIIβ along the dendritic shaft. The spatial restriction of PKARIIβ in the dendritic shaft is important for regulating PKACα activity during excitatory synaptic transmission 27 . For instance, dendritic MAP2 is considered to be a neuronal AKAP that anchors PKARIIβ along with PKACα in the dendritic shaft 40 . After cAMP binds to PKARIIβ, the catalytic subunits begin to dissociate from the complex and enter the dendritic spine 27 . Neurons derived from MAP2∆1-158 mutant mice that also display increased translocation of PKARIIβ into dendritic spines have increased PKA-dependent phosphorylation of GluR1 (ref. 27) . On the basis of these observations 27, 40 , we propose that LRRK2 acts as an additional dendritic AKAP that interacts with PKARIIβ, acting synergistically with, or independently of MAP2, particularly at the time of active dendritic spine morphogenesis. Similar to what happened in the MAP2∆1-158 mutant mice 40 , the absence of LRRK2 allowed substantially more PKACα and PKARIIβ subunits in the dendritic spines of Lrrk2 −/− neurons, which is likely to bring PKA holoenzyme closer to the upstream components of cAMP-mediated signaling transduction pathways, such as the dopamine receptors and adenylate cyclase, as well as the downstream substrates, such as the synaptic protein GluR1, resulting in the observed abnormally increased PKA activity. Thus, there may be competition between dendritic shaft AKAPs, such as MAP2 and LRRK2, and synaptic AKAPs, such as AKAP79/150 (ref. 41) , in anchoring the PKA holoenzyme in the dendritic shaft and spines. The loss of LRRK2 may shift the balance to more PKA binding with the synaptic AKAPs, leading to more PKA activity. This hypothesis is further supported by a recent computational analysis of the importance of subcellular location of PKA holoenzyme in dopamine receptor Drd1-induced activation of PKA 35 . The key revelation of the previous study is that cAMP exhibits a strong spatial gradient in the dendritic spines and shaft following dopamine activation, of which the distance between PKA and the source of cAMP is more important in controlling the PKA activity. Given the presence of Drd1 receptor, G protein (G olf ) and adenylate cyclase 5 (AC5) mainly in the dendritic spines of SPNs 35 , the increase translocation of PKA holoenzyme in the spines of Lrrk2 −/− SPNs thereby renders these neurons more sensitive to PKA activation in response to dopamine stimulation.
Considering that the predominant effects of LRRK2 occur between P5 and P15, LRRK2 may be a key negative regulator of PKA signaling at this critical time period for synaptogenesis. Consistent with this notion, PKARIIβ is important for the induction of long-term potentiation in young mice (P10-14), but not in older mice (P21-28), npg a r t I C l e S of which another protein kinase CaMKII becomes predominant 42 . Having observed morphological changes in dendritic spines as a result of LRRK2's absence, we examined excitatory synaptic transmission in Lrrk2 −/− neurons. We found a decrease in the frequency of mEPSCs in the SPNs of P15 pups, which may reflect the improper maturation of dendritic spines and synapses in these neurons. This observation is further supported by the decrease in the expression of synaptic markers such as the postsynaptic adaptor proteins PSD95 in the PSD fraction of P15 Lrrk2 −/− brains. On the other hand, the amplitude of the mEPSCs was slightly increased in P15 Lrrk2 −/− neurons, despite the overall decrease in GluR1 level in the PSD fraction. However, provided that Lrrk2 −/− neurons had less PSD proteins, further normalization of GluR1 against PSD95 protein revealed an actual increase of GluR1 in the PSD fraction of Lrrk2 −/− mice. Thus, Lrrk2 −/− neurons had overall less mature dendritic spines and synapses, but their mature spines contained more GluR1, resulting in reduced mEPSC frequency and increased mEPSC amplitude. These data are also of interest considering that increased GluR1 phosphorylation was observed in the P5 and P15 Lrrk2 −/− pups. Enhanced GluR1 phosphorylation may facilitate its trafficking to the perisynaptic sites followed by lateral diffusion into the dendritic spines 43 , which may lead to more GluR1 targeted to the postsynaptic site of mature dendritic spines in Lrrk2 −/− neurons. The increased synaptic targeting of GluR1 and the related increase of mEPSC amplitude may serve as a compensatory mechanism to salvage the overall impaired synaptic transmission due to the delay of spine maturation in Lrrk2 −/− neurons.
The impairment of synaptic transmission underlies the key pathophysiological phenotypes that appear prior to neurodegeneration in Alzheimer's disease, Parkinson's disease and other degenerative neurological disorders 44 . Parkinson's disease-related dopamine deficiency has been shown to cause substantial changes of the spine morphology and function of SPNs 3 . Golgi staining of postmortem Parkinson's disease brains revealed a 20-30% reduction in striatal spine density and a reduction of the size of the dendritic trees of SPNs 45, 46 . Together, these early studies demonstrate a critical involvement of SPNs in the pathogenic processes of Parkinson's disease. In light of the function of LRRK2 in regulating PKA activity, Drd1 in the SPNs also utilizes the PKA pathway as a means to relay extracellular dopamine stimulation to intracellular signaling transduction 1 . It should also be noted that the phenotypes of PKARIIβ knockout mice are mainly related to the striatal functions, emphasizing the requirement of PKARIIβ in motor learning and related dopaminergic signaling 18 . Thus, we suspect that Lrrk2 deficiency may interfere with the PKA signaling in the striatal SPNs and compromise their responses to dopaminergic transmission. Indeed, Drd1 agonist caused aberrant increase of PKA-mediated phosphorylation of GluR1 in the striatum of Lrrk2 −/− mice, which may be attributable to the less responsiveness of Lrrk2 −/− mice to Drd1 agonist-induced motor activity. Notably, Parkinson's disease-related Lrrk2 R1441C knock-in mice showed similar abnormal GluR1 phosphorylation and motor behavioral phenotypes as the Lrrk2 −/− mice in responding to Drd1 stimulation. These observations are also consistent with an early report that Lrrk2 R1441C knock-in mice are less responsive to amphetamine-induced locomotor activity 34 , as the main effect of amphetamine in the striatum is to cause an increase of dopamine release 47 . Given that LRRK2 functions as a dimer 48 , our data suggest the R1441C missense mutation may exert a dominant-negative effect on the regulatory function of LRRK2 in modulating PKA activity by forming a dimer with wild-type protein.
The activation of Drd1 appears to exert different effects on different types of motor activities, which increased ambulatory and fine movements, but suppressed rearing, suggesting the existence of different Drd1-invovled neural circuits in regulating specific motor outputs. The loss of LRRK2 mainly compromised ambulatory and fine motor responses to Drd1 activation. Given that LRRK2 is more abundant in a subset of SPNs at the striosomes 6 , it is of interest to determine the exact neural circuits in the striatum and basal ganglion affected by LRRK2. Notably, a recent neural tracing study found that SPNs in the striosomes can directly project to the nigrostriatal dopaminergic neurons 49 . Although the functionality of this newly defined circuit remains unknown, SPNs in the striosomes may directly modulate the excitability and dopamine release of nigrostriatal dopaminergic neurons. Given that the increase of pS845 GluR1 in the Lrrk2 −/− and Lrrk2 +/R1441C SPNs may enhance the postsynaptic transmission and activation of these inhibitory GABAnergic neurons, we suspect that Lrrk2 −/− and Lrrk2 +/R1441C SPNs may further inhibit the activity of nigrostriatal dopaminergic neurons, resulting in suppression of dopamine release. Certainly, more physiological and behavioral studies will be needed to fully understand the function of this circuit in both normal and Parkinson's disease conditions.
METhODS
Methods and any associated references are available in the online version of the paper. Immunofluorescence staining and image acquisition. Neurons were fixed in 4% paraformaldehyde (wt/vol) as described previously 8 . Briefly, they were permeabilized with Triton X-100 and incubated with 10% goat serum (vol/vol) (Sigma-Aldrich) for 1 h to block unspecific binding and incubated overnight with the primary antibody. Fluorescent images were captured using a Zeiss confocal microscope (LSM510META). Spinal intensities and areas quantification was performed using the Image J Software. Regions of interest (ROIs) were set up automatically and the green (PKARIIβ) and red (mCherry) signals within the ROIs were divided to adjacent dendritic green and red intensities. The ratio of the normalized green to red signals in each genotype represents the relative intensity of the PKARIIβ inside the spines. The data presented involve about 80-150 spines sampled from three randomly selected microscopic fields of at least three independent experiments from a person blind to the genotype of neurons. cAmP elISA determination. cAMP levels of cortical neurons of each genotype (Lrrk2 +/+ , Lrrk2 −/− ) treated or untreated with FSK were quantified by using a cAMP Elisa kit (R&D Systems) according to the manufacturer's protocol. Briefly, three independent experiments with each sample assaying in duplicates were used for the analysis. The goat antibody to mouse that was coated on the microplate binds to a monoclonal antibody specific for cAMP. The cAMP present in the samples compete with an amount of horseradish peroxidase-labeled cAMP for binding on the monoclonal antibody. A substrate solution is incubated in the microplate to determine the bound enzyme activity. The intensity of the color is inversely proportional to the concentration of cAMP in the sample. Subcellular fractionation of brains. PSD fractions were prepared from mouse brains as previously described 57 . All procedures performed at 4 °C. Mouse brains were rapidly decapitated and homogenized in four volumes of ice-cold Buffer A (0.32 M sucrose, 5 mM HEPES, pH7.4, 1 mM MgCl 2 , 0.5 mM CaCl 2 , protease and phosphatase inhibitor mixture) with Teflon homogenizer (12 strokes). Homogenized brain extract was spun at 1,400 g for 10 min. Supernatant (S1) was saved and pellet (P1) was homogenized again with Teflon homogenizer with buffer A (five strokes). After centrifugation at 700 g, the supernatant (S1′) was saved and pooled with S1. Pooled S1 and S1′ were centrifuged at 13,800 g for 10 min to collect the crude synaptosomal pellet (P2) and the supernatant (S2), which contains the cytosol and light membranes. S2 was centrifuged at 100,000 g for 15 min to produce the cytosolic fraction (S2′) and the light membrane (LM) fraction. P2 was resuspended in Buffer B (0.32M sucrose, 6mM Tris, pH 8.0 supplemented with protease and phosphatase inhibitors cocktail) with Teflon homogenizer (five strokes). The P2 suspension was loaded onto a discontinuous sucrose gradient (0.85 M/1 M/1.15 M sucrose solution in 6 mM Tris, pH 8.0), followed by centrifugation for 2 h at 82,500 g. The synaptosome fraction between 1 M and 1.15 M sucrose was collected and resuspended with 6 mM Tris with 0.5% Triton (vol/vol). The PSD fraction was purified by centrifugation at 32,800 g for 20 min.
Intraperitoneal injection of drd1 agonist SkF-81297, open-field test and western blot analysis of striatal proteins. Equal numbers of male and female mice randomly selected from each genotype were removed from the light cycle and placed in the dark room for 30 min before behavioral test. 5 min after the intraperitoneal injection of 0.9% saline, 2 mg per kg or 10 mg per kg Drd1 agonist, R(+)-SKF-81297 hydrobromide (Sigma), mice were placed in the chamber for open-field test using Flex-Field activity system (San Diego Instruments) as described previously 32, 58 . Immediately after the behavioral test, mice were decapitated and the striatal tissues were dissected out. Striatal tissues were homogenized and sonicated in 1% SDS lysis buffer and denatured at 70 °C for 10 min, as described previously 59 . 20 µg protein was resolved in 4-12% Tris-Bis NuPage gel and transferred to PVDF membrane. Blots were incubated with antibodies to total GluR1 and pS845 GluR1. Expression level and the ratios between phosphorylated and total proteins were determined using a LI-COR system and Odyssey software and expressed relative to saline vehicle controls.
Statistics. Graph Pad Prism 5 was used for statistical analysis. The data were collected and processed randomly. No statistical methods were used to predetermine sample size, but our sample sizes are similar to those reported in previous publications 25, 54, 58 . Data distribution was assumed to be normal, but this was not formally tested. Statistical significances were determined by comparing means of different groups using t test or two-way ANOVA followed by post-tests. For the box and whisker plot, the bottom and top of the box are always the first and third quartiles, and the band inside the box is always the second quartile (the median).
Corrigendum: LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity In the version of this article initially published, the line graphs presented in Figure 1g ,h were switched with ones from a different experiment.
The error has been corrected in the HTML and PDF versions of the article. 
